Clinical practice guidelines for evidence-based use of erythropoietic-stimulating agents.
Moist
Louise M
LM
Department of Medicine, University of Western Ontario, London, Ontario, Canada.
Foley
Rob N
RN
Barrett
Brendan J
BJ
Madore
Francois
F
White
Colin T
CT
Klarenbach
Scott W
SW
Culleton
Bruce F
BF
Tonelli
Marcello
M
Manns
Braden J
BJ
D000740:Anemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D015415:Biomarkers / Q000097:blood; D035843:Biomedical Research; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D004349:Drug Packaging; D019317:Evidence-Based Medicine; D006397:Hematinics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D006435:Renal Dialysis; D016896:Treatment Outcome
D015415:Biomarkers; D006397:Hematinics; D006454:Hemoglobins; D007501:Iron